What are the indications, recommended dosing regimens, and safety considerations for Keflex (cephalexin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Keflex (Cephalexin): Indications, Dosing, and Safety

Keflex is indicated for skin and soft tissue infections, streptococcal pharyngitis, uncomplicated cystitis, and respiratory tract infections, with standard adult dosing of 250 mg every 6 hours or 500 mg every 12 hours for most infections, though twice-daily dosing is equally effective and improves adherence. 1

Approved Indications

Keflex treats infections caused by susceptible organisms including:

  • Skin and soft tissue infections (including uncomplicated cellulitis)
  • Streptococcal pharyngitis
  • Uncomplicated cystitis (in patients >15 years)
  • Upper and lower respiratory tract infections
  • Otitis media (pediatric)
  • Bone and joint infections (as oral continuation therapy)

The IDSA guidelines support cephalexin for nonpurulent cellulitis, though pathogen isolation occurs in <20% of cases, making empiric therapy the norm 2.

Dosing Regimens

Adults

Standard dosing: 1

  • 250 mg every 6 hours for routine infections
  • 500 mg every 12 hours for streptococcal pharyngitis, skin/soft tissue infections, and uncomplicated cystitis
  • Total daily dose ranges from 1-4 g in divided doses
  • Cystitis requires 7-14 days of therapy

Critical dosing insight: Multiple studies demonstrate that twice-daily dosing (500 mg BID) is equally effective as four-times-daily dosing for skin infections and UTIs, with >97% efficacy and improved adherence 3, 4, 5. This is clinically important because adherence improves dramatically with less frequent dosing.

Pediatric Patients

  • Standard: 25-50 mg/kg/day in divided doses 1
  • Streptococcal pharyngitis and skin infections: Can divide total daily dose every 12 hours
  • Otitis media: 75-100 mg/kg/day in 4 divided doses
  • Severe infections: Double the dosage
  • β-hemolytic streptococcal infections: Minimum 10 days of therapy

Important caveat: A recent 2025 study shows that high-dose cephalexin 45 mg/kg (max 1.5 g) three times daily is effective and well-tolerated for bone and joint infections, achieving 99% cure rates 6. This reduced-frequency regimen improves adherence while maintaining efficacy.

Renal Dosing Adjustment

Patients with creatinine clearance <30 mL/min require proportional dose reduction based on renal function 7. Cephalexin is 70-100% renally excreted within 6-8 hours, achieving urinary concentrations of 500-1000 mcg/mL—far exceeding MIC for typical uropathogens 7.

Safety Considerations

Adverse Events

Keflex has an excellent safety profile:

  • Very low incidence of allergic reactions due to chemical stability 7
  • Minimal gastrointestinal irritation even at high doses 7
  • Does not disturb lower bowel flora (absorbed in upper intestine) 7
  • Most common side effect: diarrhea (mild intensity) 8
  • Neutropenia can occur in children on prolonged therapy but is typically mild without complications 6

Overdose Management

Symptoms include nausea, vomiting, diarrhea, and hematuria 1. Unless 5-10 times the normal dose is ingested, gastrointestinal decontamination is unnecessary. Activated charcoal may be considered. Forced diuresis, dialysis, or hemoperfusion are not beneficial 1.

Critical Pitfalls to Avoid

  1. Do not use cefdinir as a substitute for cephalexin in UTIs: A 2025 study showed cefdinir has nearly twice the failure rate (23.4% vs 12.5%) compared to cephalexin for uncomplicated UTIs, with higher rates of subsequent cephalosporin resistance 9. Cephalexin remains superior for UTI treatment.

  2. Ensure adequate duration: β-hemolytic streptococcal infections require minimum 10 days to prevent rheumatic fever 1.

  3. Consider MRSA coverage: For purulent cellulitis or when MRSA is suspected, cephalexin alone is insufficient. The IDSA guidelines note the need for agents effective against both streptococci and MRSA 2.

  4. Adjust for renal impairment: Failure to reduce dosing in patients with CrCl <30 mL/min risks drug accumulation 7.

Practical Algorithm for Dosing Selection

For skin/soft tissue infections or pharyngitis:

  • Prescribe 500 mg twice daily (improves adherence, equal efficacy to QID dosing)

For uncomplicated cystitis:

  • Prescribe 500 mg twice daily for 7-14 days
  • Avoid cefdinir as alternative

For severe infections:

  • Use 500 mg every 6 hours or consider parenteral therapy if >4 g/day needed

For pediatric infections:

  • Standard: 25-50 mg/kg/day divided BID for pharyngitis/skin infections
  • Otitis media: 75-100 mg/kg/day divided QID
  • Consider 45 mg/kg TID (max 1.5 g) for bone/joint infections to improve adherence

References

3
Research

The efficacy of twice daily cephalexin.

Pharmatherapeutica, 1981

7
Research

The pharmacology of cephalexin.

Postgraduate medical journal, 1983

Related Questions

What are the indications and dosing regimen for Keflex (cephalexin) in an adult without drug allergies, renal or hepatic impairment?
What is the appropriate liquid dose of cephalexin for a 90‑lb (≈41‑kg) patient?
When is cephalexin appropriate for treating infections caused by Gram‑positive cocci?
Can cephalexin tablets be split before administration?
For an 81-year-old man with normal renal function and a pathogen confirmed susceptible to cephalexin, is a regimen of cephalexin 500 mg three times daily for seven days appropriate?
How can I measure the diameter of a hair?
How should a postpartum woman with a breast nodule be evaluated and managed?
How should an adult patient with a troponin level of 1188 ng/L be evaluated and managed?
What are the contraindications for the various birth control methods, including combined oral contraceptives, progestin‑only pills, sub‑dermal implants, depot medroxyprogesterone injection, levonorgestrel intrauterine system, copper intrauterine device, tubal ligation, and barrier methods?
Will removal of the distal colon improve symptoms of irritable bowel syndrome?
Which statement about hyperthyroidism is false? A) It is characterized by low thyroid‑stimulating hormone (TSH) with elevated triiodothyronine (T3) and thyroxine (T4) levels; B) Symptoms include tachycardia, resting tremor, and sweating; C) It may be diagnosed after the initial diagnosis of atrial fibrillation; D) In Graves' disease it is usually accompanied by thyroid gland enlargement; E) It cannot be caused by pharmacological agents.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.